Biodexa Pharmaceticals
Quarterly Financials
| Values in thousands | 2023-12-31 | 2023-09-30 |
|---|---|---|
Revenue | $41 | $41 |
Gross Profit | -1,084 | -1,084 |
EBITDA | -1,143 | -1,143 |
EBIT | -1,180 | -1,180 |
Net Income | -1,755 | -1,755 |
Net Change In Cash | 41 | 41 |
Free Cash Flow | -1,483 | -1,483 |
Cash | 5,971 | 5,971 |
Basic Shares | 53 | 1,331 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $381 | $699 | $578 | $343 |
Gross Profit | -3,686 | -4,412 | -4,076 | -5,725 |
EBITDA | -7,161 | -7,395 | -5,659 | -22,219 |
EBIT | -7,444 | -7,738 | -6,062 | -23,436 |
Net Income | -7,079 | -7,656 | -5,460 | -22,189 |
Net Change In Cash | 381 | 699 | 578 | 343 |
Free Cash Flow | -7,089 | -7,110 | -6,328 | -9,510 |
Cash | 5,971 | 2,836 | 10,057 | 7,546 |
Basic Shares | 31 | 12 | 10 | 5 |
